首页 | 本学科首页   官方微博 | 高级检索  
     


Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial
Authors:Signe Foghsgaard MD  Louise Vedtofte MSc  Emilie S. Andersen MD  Emilie Bahne MD  Camilla Andreasen MD  Anne L. Sørensen MSc  Julie L. Forman MSc  Elisabeth R. Mathiesen MD  Jens A. Svare MD  Tine D. Clausen MD  Peter Damm MD  Jens J. Holst MD  Filip K. Knop MD  Tina Vilsbøll MD
Affiliation:1. Clinical Research, Steno Diabetes Center Copenhagen, University of Copenhagen, Herlev, Denmark;2. Clinical Research, Steno Diabetes Center Copenhagen, University of Copenhagen, Herlev, Denmark

Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark;3. Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark;4. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;5. Department of Gynaecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark;6. Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;7. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;8. Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Abstract:
Keywords:clinical trial  GLP-1  GLP-1 analogue  incretin therapy  liraglutide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号